ストックスクリーナーアプリを入手
210.93
0.60%
1.25
アフターアワーズ：
210.93
前日終値:
$209.68
開ける：
$210.57
24時間の取引高:
650.81K
Relative Volume:
0.78
時価総額：
$13.54B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
20.25
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
+0.93%
1か月 パフォーマンス:
+6.25%
6か月 パフォーマンス:
+83.87%
1年 パフォーマンス:
+54.71%
1日の値動き範囲:
$209.95
$213.82
1週間の範囲:
$206.85
$215.33
52週間の値動き範囲:
$101.00
$215.33
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
210.93 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
386.92 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
180.88 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.70 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
99.90 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita reports muted analyst consensus, shares hold above 210 dollars - AD HOC NEWS
DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now? - TradingView
DaVita expands specialized care beyond acute settings through IKC - MSN
The DaVita Care Management platform from DaVita Inc.software that keeps chronic kidney patients o - AD HOC NEWS
What are Wall Street analysts' target price for DaVita stock? - MSN
How is DaVita's stock performance compared to other healthcare stocks? - MSN
Strengthening the Transplant System: 5 Common Myths About Living Kidney Donation - DaVita Newsroom
How Is DaVita's Stock Performance Compared to Other Healthcare Stocks - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Navigating Growth Amidst a Dynamic Healthcare Landscape - DirectorsTalk Interviews
Zacks.com featured highlights include Murphy, DaVita, Hewlett Packard and Vishay - Yahoo Finance
DaVita StockWeekly outlook with focus on upcoming earnings and strategy - AD HOC NEWS
Why DaVita® In-Center Nocturnal Dialysis quietly changes patients’ nights - AD HOC NEWS
How DaVita’s New $500 Million Term Loan and Higher Guidance Will Impact DaVita (DVA) Investors - simplywall.st
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita Inc. SharesInsider sale and technical picture on Thursday - AD HOC NEWS
DaVita Inc (DVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Why DaVita Care Connect quietly changes dialysis days - AD HOC NEWS
DaVita stock gains from integrated kidney care and CKCC progress - MSN
DaVita Inc (DVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
DaVita Inc (DVA) CEO Javier Rodriguez Sells 69,407 Shares - GuruFocus
DaVita Inc (DVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DaVita legal chief K. Waters sells $3.2m in stock By Investing.com - Investing.com Nigeria
DaVita(DVA.US) Officer Sells US$14.53 Million in Common Stock - Moomoo
DaVita Insiders Sold Shares Worth Over $17M - TradingView
DaVita legal chief K. Waters sells $3.2m in stock - Investing.com
DaVita Expands Specialized Care Beyond Acute Settings Through IKC - Zacks Investment Research
DaVita Inc (DVA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DaVita Inc (DVA) Institutional Confidence - TradingKey
DaVita Inc (DVA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DaVita Inc (DVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DaVita Stock Surges 9.2%, With A 5-Day Winning Spree - Trefis
5-Day Rally Sends DaVita Stock Up 9.2% - Trefis
Expanded access, DaVita Patient-Facing Mobile App enters next phase of kidney care - AD HOC NEWS
DaVita vs. Encompass Health: Comparing Steady Patient Volumes and Growth RatesNews and Statistics - IndexBox
DaVita vs. Encompass Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
DaVita Inc. Stock (US23918K1088): Stock in focus after chart signals and a long-term return snapshot - AD HOC NEWS
DaVita gains 21.4% in three months: How should you play the stock? - MSN
DaVita Inc. Stock (US23918K1088): Valuation picture draws attention after recent gains - AD HOC NEWS
DaVita expands comprehensive kidney care through dialysis services - MSN
DaVita (DVA) Stock After 82% YTD Surge Is The Price Still Justified - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc (DVA) News, Articles, Events & Latest Updates - Stocktwits
DaVita Inc. Stock (US23918K1088): valuation metrics in focus for US dialysis provider - AD HOC NEWS
DaVita, SCA, USPI defeat class certification bid in US no-poach litigation - MLex
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress - TradingView
Are Investors Undervaluing DaVita (DVA) Right Now? - Yahoo Finance
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare - Yahoo Finance
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
1.33%
大文字化:
|
ボリューム (24 時間):